Literature DB >> 26613522

No Change in Executive Performance in ALS Patients: A Longitudinal Neuropsychological Study.

Elisabeth Kasper1, Kolja Zydatiss, Christina Schuster, Judith Machts, Daniel Bittner, Jörn Kaufmann, Reiner Benecke, Stefan Vielhaber, Stefan Teipel, Johannes Prudlo.   

Abstract

BACKGROUND/AIMS: A substantial proportion of amyotrophic lateral sclerosis (ALS) patients develop cognitive impairments. Longitudinal investigations of cognition in ALS have shown mixed results. While some authors report that cognitive performance remains stable as the disease progresses, others have found evidence for deterioration in various domains. Our objective was to investigate cognitive performance in ALS longitudinally, using the example of executive functions.
METHODS: 93 ALS patients and 73 age-, sex- and education-matched healthy controls underwent up to four neuropsychological evaluations, separated by 3- to 6-month intervals. We examined whether performance declined longitudinally on seven tests assessing various sub-components of executive functioning. Furthermore, we assigned an executive-performance-based 'cognitive status' to each participant for every evaluation, examining whether cognitive deterioration (if present) was modulated by their baseline cognitive status and whether cognitive status changed over time.
RESULTS: Regardless of their cognitive status at baseline, ALS patients showed no significant decline in the sub-components of executive functioning.
CONCLUSION: Our findings imply that the executive deficits which develop in some ALS patients emerge before motor symptoms and remain stable after an initial decline. The discrepancy between this trajectory and the progressive decline in motor functions may result from a differential vulnerability of motor and non-motor prefrontal neurons to the pathomechanism of ALS.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26613522     DOI: 10.1159/000440957

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  7 in total

1.  Cognitive impairment across ALS clinical stages in a population-based cohort.

Authors:  Adriano Chiò; Cristina Moglia; Antonio Canosa; Umberto Manera; Rosario Vasta; Maura Brunetti; Marco Barberis; Lucia Corrado; Sandra D'Alfonso; Enrica Bersano; Maria Francesca Sarnelli; Valentina Solara; Jean Pierre Zucchetti; Laura Peotta; Barbara Iazzolino; Letizia Mazzini; Gabriele Mora; Andrea Calvo
Journal:  Neurology       Date:  2019-08-13       Impact factor: 9.910

2.  CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.

Authors:  Daniela Rossi; Paolo Volanti; Liliana Brambilla; Tiziana Colletti; Rossella Spataro; Vincenzo La Bella
Journal:  J Neurol       Date:  2018-01-10       Impact factor: 4.849

3.  Screening for Cognitive Function in Complete Immobility Using Brain-Machine Interfaces: A Proof of Principle Study.

Authors:  Dorothée Lulé; Katharina Hörner; Cynthia Vazquez; Helena Aho-Özhan; Jürgen Keller; Martin Gorges; Ingo Uttner; Albert C Ludolph
Journal:  Front Neurosci       Date:  2018-08-15       Impact factor: 4.677

4.  Loss of "insight" into behavioral changes in ALS: Differences across cognitive profiles.

Authors:  Anna G M Temp; Elisabeth Kasper; Stefan Vielhaber; Judith Machts; Andreas Hermann; Stefan Teipel; Johannes Prudlo
Journal:  Brain Behav       Date:  2021-12-02       Impact factor: 2.708

5.  Cognitive reserve protects ALS-typical cognitive domains: A longitudinal study.

Authors:  Anna G M Temp; Elisabeth Kasper; Judith Machts; Stefan Vielhaber; Stefan Teipel; Andreas Hermann; Johannes Prudlo
Journal:  Ann Clin Transl Neurol       Date:  2022-07-22       Impact factor: 5.430

6.  Case Report: Cognitive Conversion in a Non-brazilian VAPB Mutation Carrier (ALS8).

Authors:  Anna G M Temp; Martin Dyrba; Elisabeth Kasper; Stefan Teipel; Johannes Prudlo
Journal:  Front Neurol       Date:  2021-06-02       Impact factor: 4.003

Review 7.  Communication Matters-Pitfalls and Promise of Hightech Communication Devices in Palliative Care of Severely Physically Disabled Patients With Amyotrophic Lateral Sclerosis.

Authors:  Katharina Linse; Elisa Aust; Markus Joos; Andreas Hermann
Journal:  Front Neurol       Date:  2018-07-27       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.